Perspectives from the pandemic epicenter: Sexual and reproductive health of immigrant women in New York City
Perspectives on Sexual and Reproductive Health · 2024
DOI: 10.1111/psrh.12260 ↗Kurz gefasst
Fachartikel in der Zeitschrift Perspectives on Sexual and Reproductive Health, 2024. Verfasst von Goleen Samari und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Population and Public Health Sciences, University of Southern California, Los Angeles, California, USA. Hauptthemen laut MEDLINE: COVID-19, Emigrants and Immigrants, Sexual Health, Reproductive Health. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NICHD NIH HHS.
Abstract (Originalsprache)
Context
The United States' response to COVID‐19 created a policy, economic, and healthcare provision environment that had implications for the sexual and reproductive health (SRH) of racialized and minoritized communities. Perspectives from heterogenous immigrant communities in New York City, the pandemic epicenter in the United States (US), provides a glimpse into how restrictive social policy environments shape contraception, abortion, pregnancy preferences, and other aspects of SRH for marginalized immigrant communities.
Methods
We conducted in‐depth interviews in 2020 and 2021 with 44 cisgender immigrant women from different national origins and 19 direct service providers for immigrant communities in New York City to explore how immigrants were forced to adapt their SRH preferences and behaviors to the structural barriers of the COVID‐19 pandemic. We coded and analyzed the interviews using a constant comparative approach.
Results
Pandemic‐related fears and structural barriers to healthcare access shaped shifts in contraceptive use and preferences among our participants. Immigrant women weighed their concerns for health and safety and the potential of facing discrimination as part of their contraceptive preferences. Immigrants also described shifts in their pregnancy preferences as rooted in concerns for their health and safety and economic constraints unique to immigrant communities.
Conclusion
Understanding how immigrant women's SRH shifted in response to the structural and policy constraints of the COVID‐19 pandemic can reveal how historically marginalized communities will be impacted by an increasingly restrictive reproductive health and immigration policy landscape.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Population and Public Health Sciences, University of Southern California, Los Angeles, California, USA.
- Heilbrunn Department of Population and Family Health, Mailman School of Public Health, Columbia University, New York, New York, USA.
- Anthropology Department, University of Connecticut, Storrs, Connecticut, USA.
- Research Program on Global Health & Human Rights, Human Rights Institute, University of Connecticut, Storrs, Connecticut, USA.
- Population Studies and Training Center, Brown University, Providence, Rhode Island, USA.
- Coalition to Expand Contraceptive Access, Oakland, California, USA.
Förderung
- NICHD NIH HHS
Zitieren
APA
Samari, G., Wurtz, H. M., Desai, S., & Coleman-Minahan, K. (2024). Perspectives from the pandemic epicenter: Sexual and reproductive health of immigrant women in New York City. Perspectives on Sexual and Reproductive Health. https://doi.org/10.1111/psrh.12260
Vancouver
Samari G, Wurtz HM, Desai S, Coleman-Minahan K. Perspectives from the pandemic epicenter: Sexual and reproductive health of immigrant women in New York City. Perspectives on Sexual and Reproductive Health. 2024. doi:10.1111/psrh.12260
BibTeX
@article{Samari2024,
author = {Samari, Goleen and Wurtz, Heather M and Desai, Sheila and Coleman-Minahan, Kate},
title = {Perspectives from the pandemic epicenter: Sexual and reproductive health of immigrant women in New York City},
journal = {Perspectives on Sexual and Reproductive Health},
year = {2024},
doi = {10.1111/psrh.12260}
}
EUVIMED